← FDA DRUG APPROVALS

FDA ANDA · ANDA040336

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Sponsor: HIKMA

APPLICATION
ANDA040336
TYPE
ANDA
ORIGINAL APPROVAL
1999-08-18
LATEST ACTION
1999-08-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BUTALBITAL, ACETAMINOPHEN AND CAFFEINEDiscontinued
ACETAMINOPHEN 500MG, BUTALBITAL 50MG, CAFFEINE 40MG · TABLET · ORAL

Approval history

1999-08-18OriginalOtherAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →